novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Cardiovascular risk in diabetics and treatment benefits of oral agents

6 Julho 2015

José Luís Medina
Diretora do Serviço de Medicina Intensiva Centro Hospitalar Leiria-Pombal

RESUMO DA APRESENTAÇÃO

APRESENTAÇÃO

POLYPILL a new kid on the block

6 Julho 2015
0

Peripheral artery disease. How the interventionists may help

6 Julho 2015
0

-->